Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial
- PMID: 9843006
- DOI: 10.1016/s0190-9622(98)70267-1
Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial
Abstract
Background: Tinea versicolor is a common superficial fungal infection caused by a lipophilic yeast. This chronically recurring opportunistic infection is especially prevalent in tropical and semitropical regions. The topical short-term application of ketoconazole 2% shampoo may provide effective and safe therapy for tinea versicolor.
Objective: The purpose of this study was to evaluate the efficacy and safety of a single application (1 day) versus three daily applications (3 days) of ketoconazole 2% shampoo versus placebo shampoo in the treatment of mycologically confirmed tinea versicolor.
Methods: Three hundred twelve patients were included in the primary analyses for this 31-day study. Global evaluation scores were measured on days 10 and 31 with a 5-point scale (1 = healed to 5 = worsening), and a cellophane tape test was done at baseline and days 3, 10, and 31. Efficacy was assessed by clinical response, defined as both a global evaluation score of 1 (healed) and a negative cellophane tape test on day 31. Signs and symptoms of tinea versicolor (scaling, itching, erythema, hypopigmentation, hyperpigmentation) also were evaluated at baseline, day 10, and day 31 with a 4-point scale (0 = absent to 3 = severe).
Results: Both regimens of ketoconazole shampoo were significantly (P < .001) more effective than placebo for rate of clinical response, global evaluation scores, and mycologic outcomes (cellophane tape test). The clinical response rates at day 31 were 73%, 69%, and 5% for the 3-day ketoconazole, 1-day ketoconazole, and placebo groups, respectively. The difference in the efficacy of the two ketoconazole treatment regimens was not statistically significant. There were no significant differences between any of the treatment groups in the number of patients who experienced adverse events. No serious adverse events occurred and no patient withdrew from the trial prematurely because of an adverse event.
Conclusion: Ketoconazole 2% shampoo, used as a single application or daily for 3 days, is safe and highly effective in the treatment of tinea versicolor.
Similar articles
-
Flutrimazole shampoo 1% versus ketoconazole shampoo 2% in the treatment of pityriasis versicolor. A randomised double-blind comparative trial.Mycoses. 2007 May;50(3):193-5. doi: 10.1111/j.1439-0507.2006.01352.x. Mycoses. 2007. PMID: 17472615 Clinical Trial.
-
Can pityriasis versicolor be treated with 2% ketoconazole foam?J Drugs Dermatol. 2014 Jul;13(7):855-9. J Drugs Dermatol. 2014. PMID: 25007370 Clinical Trial.
-
Clinical efficacies of shampoos containing ciclopirox olamine (1.5%) and ketoconazole (2.0%) in the treatment of seborrhoeic dermatitis.J Dermatolog Treat. 2007;18(2):88-96. doi: 10.1080/16537150601092944. J Dermatolog Treat. 2007. PMID: 17520465 Clinical Trial.
-
Diagnosis and treatment of tinea versicolor.J Fam Pract. 1996 Aug;43(2):127-32. J Fam Pract. 1996. PMID: 8708621 Review.
-
Topical ketoconazole: a systematic review of current dermatological applications and future developments.J Dermatolog Treat. 2019 Dec;30(8):760-771. doi: 10.1080/09546634.2019.1573309. Epub 2019 Feb 14. J Dermatolog Treat. 2019. PMID: 30668185
Cited by
-
Antifungal agents for common paediatric infections.Paediatr Child Health. 2000 Nov;5(8):477-91. doi: 10.1093/pch/5.8.477. Paediatr Child Health. 2000. PMID: 20177562 Free PMC article. No abstract available.
-
Antifungal Treatment for Pityriasis Versicolor.J Fungi (Basel). 2015 Mar 12;1(1):13-29. doi: 10.3390/jof1010013. J Fungi (Basel). 2015. PMID: 29376896 Free PMC article. Review.
-
What is in a name?West J Med. 2000 Oct;173(4):231-2. doi: 10.1136/ewjm.173.4.231. West J Med. 2000. PMID: 11017976 Free PMC article. No abstract available.
-
Anti-dandruff effects of butterfly pea flowers (Clitoria ternatea)-based shampoo: A pretest-posttest control study.Narra J. 2024 Aug;4(2):e876. doi: 10.52225/narra.v4i2.876. Epub 2024 Aug 12. Narra J. 2024. PMID: 39280272 Free PMC article.
-
Antifungal agents for common paediatric infections.Can J Infect Dis Med Microbiol. 2008 Jan;19(1):15-8. Can J Infect Dis Med Microbiol. 2008. PMID: 19145261 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical